CoChat
Sign Up
Cited by 139

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome

Kuo, Caroline Y., Long, Joseph D., Campo-Fernandez, Beatriz, de Oliveira, Satiro, Cooper, Aaron R., Romero, Zulema, Hoban, Megan D., Joglekar, Alok V., Lill, Georgia R., Kaufman, Michael L., Fitz-Gibbon, Sorel, Wang, Xiaoyan, Hollis, Roger P., Kohn, Donald B.·2018·Cell Reports
DOI 10.1016/j.celrep.2018.04.103PMC PMC6181643
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2018.04.103

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 33

  1. Abraham, 2016, Flow cytometry, a versatile tool for diagnosis and monitoring of primary immunodeficiencies, Clin. Vaccine Immunol., 23, 254, 10.1128/CVI.00001-16 · DOI
  2. Anderson, 2010, Post-transcriptional regulons coordinate the initiation and resolution of inflammation, Nat. Rev. Immunol., 10, 24, 10.1038/nri2685 · DOI · Paper page
  3. Brown, 1998, Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice, Nat. Med., 4, 1253, 10.1038/3233 · DOI
  4. Cermak, 2011, Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting, Nucleic Acids Res., 39, e82, 10.1093/nar/gkr218 · DOI
  5. Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 · DOI · Paper page
  6. Cooper, 2011, Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration, J. Virol. Methods, 177, 1, 10.1016/j.jviromet.2011.06.019 · DOI
  7. Covey, 2015, The RNA-binding protein, polypyrimidine tract-binding protein, affects multiple events in CD4 T cell activation through distinct processes, J. Immunol., 194, 18, 10.4049/jimmunol.194.Supp.61.18 · DOI
  8. Critchlow, 1991, On distribution-free multiple comparisons in the one-way analysis of variance, Commun. Stat. Theory Methods, 20, 127, 10.1080/03610929108830487 · DOI
  9. de la Morena, 2017, Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation, J. Allergy Clin. Immunol., 139, 1282, 10.1016/j.jaci.2016.07.039 · DOI
  10. De Oliveira, 2013, Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy, Hum. Gene Ther., 24, 824, 10.1089/hum.2012.202 · DOI
  11. De Ravin, 2016, Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease, Nat. Biotechnol., 34, 424, 10.1038/nbt.3513 · DOI · Paper page
  12. Doyle, 2012, TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction, Nucleic Acids Res., 40, W117, 10.1093/nar/gks608 · DOI
  13. Dull, 1998, A third-generation lentivirus vector with a conditional packaging system, J. Virol., 72, 8463, 10.1128/JVI.72.11.8463-8471.1998 · DOI · Paper page
  14. Epinat, 2003, A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells, Nucleic Acids Res., 31, 2952, 10.1093/nar/gkg375 · DOI
  15. Fine, 2014, An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage, Nucleic Acids Res., 42, e42, 10.1093/nar/gkt1326 · DOI
  16. Gabriel, 2011, An unbiased genome-wide analysis of zinc-finger nuclease specificity, Nat. Biotechnol., 29, 816, 10.1038/nbt.1948 · DOI · Paper page
  17. Gennery, 2004, Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002, Blood, 103, 1152, 10.1182/blood-2003-06-2014 · DOI
  18. Gwiazda, 2016, High efficiency CRISPR/Cas9-mediated gene editing in primary human T-cells using mutant adenoviral E4orf6/E1b55k “helper” proteins, Mol. Ther., 24, 1570, 10.1038/mt.2016.105 · DOI
  19. Hayward, 1997, Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM, J. Immunol., 158, 977, 10.4049/jimmunol.158.2.977 · DOI
  20. Hoban, 2015, Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells, Blood, 125, 2597, 10.1182/blood-2014-12-615948 · DOI · Paper page
  21. Hollenbaugh, 1994, The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1, J. Clin. Invest., 94, 616, 10.1172/JCI117377 · DOI
  22. Hubbard, 2016, Targeted gene editing restores regulated CD40L expression and function in X-linked hyper-IgM syndrome, Blood, 127, 2513, 10.1182/blood-2015-11-683235 · DOI
  23. Levy, 1997, Clinical spectrum of X-linked hyper-IgM syndrome, J. Pediatr., 131, 47, 10.1016/S0022-3476(97)70123-9 · DOI
  24. Mitsui-Sekinaka, 2015, Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan, J. Allergy Clin. Immunol., 136, 1018, 10.1016/j.jaci.2015.02.020 · DOI
  25. Petrovic, 2009, Hematopoietic stem cell transplantation for pediatric patients with primary immunodeficiency diseases at All Children’s Hospital/University of South Florida, Immunol. Res., 44, 169, 10.1007/s12026-009-8111-z · DOI
  26. Romero, 2011, A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences, Gene Ther., 18, 364, 10.1038/gt.2010.144 · DOI
  27. Sacco, 2000, Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome, Cancer Gene Ther., 7, 1299, 10.1038/sj.cgt.7700232 · DOI
  28. Saifuddin, 2013, Phosphorylation and the regulation of CD40L mRNA stability by polypyrimidine tract binding protein (P1394), J. Immunol., 190, 14, 10.4049/jimmunol.190.Supp.203.14 · DOI
  29. Satomura, 2017, Precise genome-wide base editing by the CRISPR Nickase system in yeast, Sci. Rep., 7, 2095, 10.1038/s41598-017-02013-7 · DOI
  30. Schiroli, 2017, Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1, Sci. Transl. Med., 9, eaan0820, 10.1126/scitranslmed.aan0820 · DOI · Paper page
  31. Steel, 1960, A rank sum test for comparing all pairs of treatments, Technometrics, 2, 197, 10.1080/00401706.1960.10489894 · DOI
  32. Vavassori, 2009, Post-transcriptional regulation in lymphocytes: the case of CD154, RNA Biol., 6, 259, 10.4161/rna.6.3.8581 · DOI
  33. Yew, 1990, Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis, Virology, 179, 795, 10.1016/0042-6822(90)90147-J · DOI

Cited by

See all 139

Metadata

Authors
Kuo, C. Y., Long, J. D., Campo-Fernandez, B., de Oliveira, S., Cooper, A. R., Romero, Z., Hoban, M. D., Joglekar, A. V., Lill, G. R., Kaufman, M. L., Fitz-Gibbon, S., Wang, X., Hollis, R. P., & Kohn, D. B.
ORCID
Kuo, Caroline Y.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2018-05
Volume
23
Issue
9
Pages
2606-2616
ISSN
2211-1247
DOI
10.1016/j.celrep.2018.04.103
PMC
PMC6181643
Cited by
139
References
8
Language
en
Licence
Funders
  • University of California, Los Angeles (K12HD34610-20, K12HD34610-19)
  • California Institute for Regenerative Medicine (DISC2-10124)
  • Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles
  • Australasian Society of Clinical Immunology and Allergy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. https://app.cochat.ai/papers/10.1016/j.celrep.2018.04.103
The paper
Kuo, C. Y., Long, J. D., Campo-Fernandez, B., de Oliveira, S., Cooper, A. R., Romero, Z., Hoban, M. D., Joglekar, A. V., Lill, G. R., Kaufman, M. L., Fitz-Gibbon, S., Wang, X., Hollis, R. P., & Kohn, D. B. (2018). Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. Cell Reports. https://doi.org/10.1016/j.celrep.2018.04.103